MEDICENNA THERAPEUTICS CORP. Common Shares SALES AGREEMENTSales Agreement • February 17th, 2023 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • New York
Medicenna Therapeutics Corp., a corporation existing under the laws of Canada (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”), as follows:
MEDICENNA THERAPEUTICS CORP. as the Corporation and TSX TRUST COMPANY as the Warrant Agent WARRANT INDENTURE Providing for the Issue of Warrants Dated as of December 21, 2018Warrant Indenture • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • Ontario
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE OR CONFIDENTIAL.Cancer Research Grant Contract • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and Medicenna Therapeutics, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE OR CONFIDENTIAL.Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • Ontario
THIS EMPLOYMENT AGREEMENT (the “Agreement”) dated for reference the 1st day of January, 2013 (the “Effective Date”), and amended the 1st day of March 2015 (the “Amendment #1 Date”), and further amended the 1st day of October 2016 (the “Amendment #2 Date”).
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBITBECAUSE IT IS BOTH (I)NOT MATERIAL AND (II)THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE OR CONFIDENTIAL. AMALGAMATION...Amalgamation Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • British Columbia
A2 ACQUISITION CORP., a body corporate, incorporated under the laws of the Province of Alberta, having an office in the City of Calgary, in the Province of Alberta (“A2”);
July 28, 2021 Elizabeth WilliamsEmployment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE OR CONFIDENTIAL. Revised...Exclusive Equity Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • California
This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY ("Stanford"), an institution of higher education having powers under the laws of the State of California, and Medicenna Therapeutic, Inc. ("Medicenna"), a corporation having a principal place of business at 1300 – 1500 West Georgia Street, Vancouver, BC, V6G 2Z6, is effective on the 21st day of August, 2015 ("Effective Date").
September 21, 2017 Elizabeth Williams 1920 Yonge Street, 2nd Floor Toronto, ON Dear Elizabeth:Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
We are asking you to agree to certain changes to your written employment agreement dated December 12, 2016 (your “Employment Agreement”) a copy of which is enclosed with this amendment letter).
July 28, 2021 Rosemina Merchant.Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
November 3, 2020 Rosemina Merchant. Toronto, ON M4W 3E2 Dear Rosemina,Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
We are asking you to agree to certain changes to the written employment agreement dated January 1, 2013 as amended March 1, 2015, October 1, 2016 and September 21, 2017 (your "Employment Agreement") a copy of which is enclosed with this amendment letter).
November 3, 2020 Elizabeth Williams Toronto, ON M4W 3E2 Dear Elizabeth,Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
We are asking you to agree to certain changes to the written employment agreement dated December 12, 2016 as amended September 21, 2017 (your "Employment Agreement") a copy of which is enclosed with this amendment letter).
NATIONAL INSTITUTES OF HEALTH START-UP PATENT LICENSE AGREEMENT — EXCLUSIVE COVER PAGEStart-Up Patent License Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • District of Columbia
This Start-Up Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options). The Parties to this Agreement are:
November 3, 2020 Fahar Merchant Toronto, ON M4W 3E2 Dear Fahar,Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
We are asking you to agree to certain changes to the written employment agreement dated January 1, 2013 as amended March 1, 2015, October 1, 2016 and September 21, 2017 (your "Employment Agreement") a copy of which is enclosed with this amendment letter).
AMENDMENT TO EXCLUSIVE (EQUITY) AGREEMENTSExclusive (Equity) Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • California
This is an amendment (this “Amendment”) to the Exclusive (Equity) Agreement for Stanford dockets S11-072 and S11-184 (the “Agreement”) entered into as of August 21, 2015 between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education having powers under the laws of the State of California, and Medicenna Therapeutics, Inc. (“Medicenna”), a corporation having a principal place of business at 2 Bloor St. W, 7th Floor, Toronto, Ontario M4W 3E2 (each a “Party” and collectively the “Parties”).
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE OR CONFIDENTIAL. Revised...Exclusive Equity Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • California
This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY ("Stanford"), an institution of higher education having powers under the laws of the State of California, and Medicenna Therapeutic, Inc. ("Medicenna"), a corporation having a principal place of business at 1300 – 1500 West Georgia Street, Vancouver, BC, V6G 2Z6, is effective on the _21st_ day of August, 2015 ("Effective Date").
July 28, 2021 Fahar MerchantEmployment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
September 21, 2017 Rosemina (Nina) Merchant 1920 Yonge Street, 2nd Floor Toronto, ON Dear Nina:Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
We are asking you to agree to certain changes to your written employment agreement dated January 1, 2013 as amended March 1, 2015 and October 1, 2016 (your "Employment Agreement") a copy of which is enclosed with this amendment letter).
AMENDMENT TO EXCLUSIVE (EQUITY) AGREEMENTSExclusive (Equity) Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • California
This is an amendment (this “Amendment”) to the Exclusive (Equity) Agreement for Stanford dockets S10-200 and S14-174 (the “Agreement”) entered into as of August 21, 2015 between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education having powers under the laws of the State of California, and Medicenna Therapeutics, Inc. (“Medicenna”), a corporation having a principal place of business at 2 Bloor St. W, 7th Floor, Toronto, Ontario M4W 3E2 (each a “Party” and collectively the “Parties”).
September 21, 2017Employment Agreement • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations
We are asking you to agree to certain changes to your written employment agreement dated January 1, 2013 and as amended March 1, 2015 and October 1, 2016 (your “Employment Agreement”) a copy of which is enclosed with this amendment letter).
